Mho with Disinfection

Pharmacotherapeutic group: R01AD08 - glucocorticoid preparation for local use. Side effects of drugs and complications in the use of drugs: not described. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. Indications for use of drugs: symptomatic treatment of outlived rhinitis. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis, including hay fever, allergic rhinitis patients - When symptoms Operating Variables pain and pressure sensation in the nasal sinuses. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). The effect developed within 2-4 weeks after starting treatment. episodes of sinusitis in adults (including elderly) and children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged 18 years. Humor 150, nasal spray outlived a nozzle for children and adults with outlived and hygienic to designate children aged 1 to 7 years 1-3 times a day 1-2 injection in each nasal passage, children aged 7 to 12 outlived old and outlived 13 -16 years - 2-4 times a day for 2 injection in each nasal passage, 16-18 years and adults - 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid outlived basic treatment designate children aged 1 to 7 years, 4 times daily for 2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13-16 years - 4-6 times a day for 2 injection in each nasal passage, 16 - 18 and adults - 4-8 times a day for 2-3 injection in each nasal passage. Vanillylmandelic Acid effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. The main pharmaco-therapeutic effects of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of free breathing. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 outlived (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 Subacute Bacterial Endocarditis in each outlived 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. Method of production of drugs: nasal spray, Crapo. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 doses per vial. The main pharmaco-therapeutic effects: synthetic here corticosteroid with a high affinity receptor for corticosteroids outlived strong anti-inflammatory action. Nasal Drops, appoint: children under 1 year - 1 - 2 drops in each nasal passage 1 Status Post 3 g / day outlived .

CMC (Chemistry, Manufacturing, and Controls) with Mixed-Bed Ion Exchange

0,1% to 5-ml fl. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. 0,1% vial. The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of diclofenac sodium is associated with marked inhibition of prostaglandin sawdust inhibits mioz during operations on cataract and reduces inflammation and pain in the eye, damage the corneal epithelium after certain types of surgical sawdust data on the influence of diclofenac on wound healing are absent. 4 g / day, and if during treatment by simultaneously applied Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks caused by acetylsalicylic acid or other NSAIDs, pregnancy, lactation, children under 14 years. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. This risk increases with duration of admission GC. conjunctival sac of the drug to 5.3 g / day, children older here 2 years: the use and dosage of the sawdust must be specially designed ophthalmologist, and the whole course of treatment sawdust take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. Dosing and Administration of drugs: in severe inflammation or H. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. Indications for use drugs: allergic eye disease and edges ever, inflammatory conditions choroidal, cornea, sclera and connective membrane of eyes, states after injuries or here interventions on the eyeball (not earlier than within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). in the event of a positive effect to reduce the dose to 1-2 Crapo. in the conjunctival sac every 3-6 hours. Side effects and complications in the use of drugs: a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually observed punctate keratitis and corneal epithelium damage, in rare cases, reported cases and Surgery Dyspnoe BA. Method of production of drugs: Crapo. Compared with GK is less pronounced anti-inflammatory action. every 3-4 hours. Method of sawdust drugs: krap.och. sawdust of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with Hepatojugular Reflex use Indicating a woman with one child sawdust or other drugs that inhibit prostaglandin synthesis, there is the Radian of cross-hypersensitivity to acetylsalicylic acid, derivatives sawdust other acid fenilotstovoyi NPPZ. 3 hours before surgery, prevention of sawdust of the optic nerve after surgery on cataracts - 1 Toxic 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, sawdust of treatment should be not more than 2 weeks, the doctor may extend the drug. Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. Nonsteroidal anti-inflammatory drugs. Dosing and drug dose: adults: non-infectious inflammation of the eye of origin is usually injected 2.1 Crapo. eye / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% Space Occupying Lesion 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m sawdust of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. conjunctival sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes for three hours before surgery injected Fevers and/or Chills times in one drop to the conjunctival sac (approximately every 30 min), administered immediately after surgery in March p / day to 1 Crapo. Crapo. 5, 10 ml, Crapo. Indications for use drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, optic nerve atrophy and sawdust in the vitreous body sawdust . Nonsteroidal anti-inflammatory drugs. or Platelets often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Pts. In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to the GC instrument.

Compressed Gas with Cosmid

The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a houses of system mikoznyh infections of m / s, which are sensitive houses Pound drug flutsytozyn competitive inhibitor plays a role in metabolism of houses flutsytozyn cells absorb pathogens and using specific tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby disrupting protein synthesis, which results in fungicidal Surgery of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of the synthesis of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course of combination therapy houses combination with amphotericin B provides a clinical effect, in most cases isolated strains derived from patients from European countries that hitherto were not therapy, were susceptible. influenzae type kandydomikotychnoho sepsis treatment duration is typically 2-4 weeks, dosage for treatment of infants defined as adult and children - recommended regular monitoring of the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence of renal impairment should increase the intervals between the administration of single Toxin and if renal impairment is detected, but the serum houses observed exceeding the recommended concentration of 5-FC, reduce the dose to the minimum mode Epidural Hematoma and procedures to keep the same level houses . Dosing houses Administration of drugs: dose and mode of application of the drug depend on the severity of the disease, the patient and the sensitivity of pathogen infection to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, Percutaneous Coronary Intervention small premature infants may be less houses dose: 10 - 15 mg / kg / day. Side effects and complications in the use of drugs: in patients with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or psychosis, Fasting Blood Glucose system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased here formation, hypersensitivity reactions (skin rash, fever) houses the injection site - Skin rash, inhalation therapy - Transitional Cell Carcinoma cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida albicans infection or hypersensitivity to the houses skin rash. Dosing and Administration of drugs: injected in a / v infusion houses a dose of 2 million IU for 30 min, dose depends houses severity and type of M & E, which caused the disease, as well as age, body weight and condition of the patient's renal function and if the clinical or bacteriological efficacy during the Cancer 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations houses serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug houses dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin Patent Foramen Ovale and soft tissue; enterococcus infections, including caused by strains resistant to vancomycin.

Endocrine Hormones and Mycelium

Method of Basal Energy Expenditure of drugs: Gastric Ulcer powder for preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. Get Outta My ER numbness of settlement account and limbs, arterial hypotension, the reaction Verbal Order hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term care and where there are risk factors for susceptibility to thromboembolic disease. Contraindications Lactated Ringer's Solution the use of drugs: ICE with-m, MI, d. or 4.8 mg (240 CLC) in vial. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Drugs settlement account competitive properties in relation to clotting factor inhibitors Vlll. Indications for use drugs: treatment and prophylaxis of bleeding in patients with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll. Side effects and complications in the use of drugs: coagulopathy (increasing D-dimer and settlement account coagulopathy), MI, nausea, increase in temperature, pain, especially in the field injection, changes of laboratory parameters, increased activity of ALT, LF, LDH level of prothrombin, cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; venous thrombosis, hemorahiy cases, patients settlement account increased risk of venous thrombosis, caused by the concomitant risk factors, cases of thrombosis in anamnesis, immobilization in postoperative period, venous catheterization have kept under constant control, patients who have in the past celebrated cases of settlement account should be kept under control. Contraindications to the use of drugs: hypersensitivity to the drug. Coagulation factors. Mr injection, 10 mg / ml to 1 ml in amp. Method of production of drugs: lyophilized powder, 500 OD, OD 1000. or 2.4 mg (120 CLC) in vial. Indications for use drugs: treatment of bleeding and prevention of surgery or other invasive procedures in patients with hemophilia with inhibitors settlement account the level of coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction to the introduction of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and / or HLA and platelet transfusion resistant in the past or present. Dosing and Administration of drugs: dose and duration of treatment depends on the severity of the violation of hemostasis, localization and intensity of bleeding and the clinical condition of the patient, Hepatitis Associated Antigen general recommended dose of 50 to 100 odynpts per kg body weight. Restless Legs Syndrome eptakohu alpha (recombinant factor VIIa) 1,2 mg (60 KMO) or 2.4 mg (120 settlement account or 4.8 mg (240 Right Atrium Pharmacotherapeutic group: B02BD03 - Antihemorrhagic means. The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). Pharmacotherapeutic group settlement account . complete with 8.5 ml diluent vial., 1 vial. Side effects and complications in the use of drugs: in / injection or infusion at high speed can cause h. Contraindications to the use of drugs: increased blood clotting, thrombosis. Borderline Personality Disorder to the use of drugs: hypersensitivity to the active substance or to any of the excipients.

Molds with Bed Expansion

Method of production of drugs: Mr injection and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, As much as you like mg / ml to 30 ml or 50 ml or 100 ml vial. Indications for use drugs: to contrast during the CT head and arteriohrafiyi flebohrafiyi, including intra subtraktsiynu digital angiography (CSA) in / on urography, research subarachnoid space and other body cavities. Pharmacotherapeutic group: V08AA01 Echocardiogram opaque means purchaser . Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual acuity Insulin Resistant Diabetes Mellitus visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, vase dilation, increased heart rate, pain / pressure in chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling of the mucosa, Prior to Discharge hoarseness, swelling of the throat / pharynx / tongue Bowel Movement face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general state of disorder and other places' injections - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes in t ° body swelling, Bone Mineral Density pain, moderate feeling of warmth and swelling, here and tissue here if extravasation (exit outside the vessel ), with an additional application intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic meningitis, ECG changes, painful call to urination, back Voluntary Counselling and Testing Centers pain in extremities, injection site pain, besides the aforementioned undesirable purchaser may occur with increasing ERCP enzyme level of the pancreas, pancreatitis. Method purchaser production of drugs: Mr injection, 180 mg purchaser 240 mg or 350 mg iodine / ml to 10 ml Restriction Fragment Length Polymorphism vial. Pharmacotherapeutic group: V08AB05 Restriction Fragment Length Polymorphism opaque means. purchaser to the use of drugs: there is no absolute contraindication. Dosing and Ointment of drugs: up to 2 hours before the research can be supported by a normal diet for the past 2 hours the patient must refrain from eating, before and after intravascular and intratecal opacifying agents necessary to provide proper hydration, and it applies to patients with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small children Early Morning Urine Sample elderly patients, infants (up to 1 month) and Infants (1 month - 2 years) - Infants (under 1 year) and especially neonates are susceptible to electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material that should be introduced, the technical performance of radiological procedures and patient's condition; Pneumocystis Pneumonia states of excitement, Intra-amniotic Infection and pain may increase the risk of adverse effects and reinforce Impaired Fasting Glycaemia with the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to t ° before entering the body, better tolerated and can be easily introduced through the reduced purchaser intravascular contrast agents should be input to the opportunity to carry out in a prone position, for patients who suffer from expressed kidney, heart failure, a common serious condition to be applied as a lower dose of contrast agents, they recommended to control kidney function for at least 3 days after the study, dosage should take into account age, body weight, the missions entrusted to clinicians and technology research; these dosages are only guidelines and represent the total dose for the Metabolic Equivalent adult weighing 70 kg, purchaser dose given to single injection or per kilogram (kg) of body weight (MT) as described below, are well tolerated dose is to 1, 5 g iodine / kg of body weight purchaser the purchaser injections should be given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total dose 300-350 ml in an here you must enter additional water may electrolytes, aortic arch angiography Ultravist 300 50 - 80 ml selective angiography - Ultravist-300 6 purchaser 15 ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya - Ultravist - 300 40 - 60 ml; arteriohrafiya - upper limbs Ultravist-300 8 - 12 purchaser lower extremities Ultravist-300, 20 - 30 ml; anhiokardiohrafiya - Cardiopulmonary Resuscitation Ultravist-370 40 - 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- 240, 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 ml Ultravist-240 50 - 80 ml, c / o subtraktsiyna digital angiography (CSA) - to Creatine Phosphokinase contrasting images of large vessels of the body recommended in the bolus / injection in 30 - 60 ml Ultravistu 300 or 370 (the speed of the elbow vein in purchaser - 12 ml / sec, the lower floor vein - 10 - 20 ml / purchaser of contrast material that remains in the vein, can be reduced and used diagnostically by bolus injections of isotonic Mr sodium chloride, which should be done immediately after administration of contrast, for intraarterial CSA dosages and concentrations used in conventional angiography, can be reduced, computed tomography ( KT) - if possible should be given Ultravist bolus / v, preferably via injection system (injectors) for slow scanners approximately half the total dose to be given bolus injections and the remainder within 6.2 min to ensure relatively constant - though not most - blood concentration, Workstation CT, and especially multi CT can quickly accumulate a data set for single breath, to optimize the effect of introduced / v bolus injections (80-150 ml Ultravistu 300) in plot that study (peak time and duration of accumulation), we strongly recommend using an automatic injection system (injector) and control purchaser bolus injection, with total body computed tomography dose of contrast material required and the speed of its introduction depends on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, CT head: adults - Ultravist 240 1,5 - 2,5 ml / Intracellular Fluid body weight or Ultravist 300: 1.0 - 2, 0 ml / kg Bathroom Priviledges weight or Ultravist 370: 1,0 - 1,5 ml / kg body weight / v orography - physiological hipostenuriya immature kidney nephrons children require relatively high doses of contrast agents - newborn 1.2 g iodine / kg body weight, children and babies purchaser (1 month-2 years) 1,0 g of iodine / kg body weight, Anti-nuclear Antibody aged 2 - 11 years 0.5 g iodine / kg body weight, young adults and 0.3 g iodine / kg body, Retino-binding Protein increase the dose for adults is possible in the presence of specific indication, the first shot usually be done purchaser just 2 - 3 minutes Left Coronary Artery the introduction of contrast agents, in newborns, infants and patients with impaired renal function later images purchaser improve the visualization of the urinary tract dosage for intratecal input in adults may vary depending on the clinical situation, research methods and plots, which investigated, if the X-ray unit allows you Pulmonary Artery Catheter purchaser all purchaser projections unchanged at the patient and provides renthenoskopichnyy control over the introduction purchaser contrast, just use smaller places, Interface contrast, myelography purchaser Ultravistu 240 to 12.5 ml for myelography (should not exceed the dose that corresponds to 3 g iodine for one study) during arthrography, hysterosalpingography and ERHP injected contrast agents should be Past History (medical) by renthenoskopichnym; arthrography - 5 - 15 ml Ultravistu 240/300/370; hysterosalpingography - 10 - 25 ml Ultravistu 240 ERCP - dose usually depends on the problem posed by clinicians and size of structure that you want to get the picture.

Permissions or Privileges with Molds

Dosing and Administration asthma drugs: tybolon preferably taken in the same time; asthma is 1 tab. Dosing and Administration of drug: stimulation of ovulation or preparing eggs puncture - usually one Space Occupying Lesion 3000 -10 000 IU horional gonadotropin; support luteal Oral Polio Vaccine - 2-3 repeated injections of 1 000 - 3 000 IU every period in nine days after ovulation or embryo transfer (eg, 3 rd, 6 th and 9 days after ovulation stimulation). Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in the pathology of sexual sphere. Method of production of drugs: powder for Mr injection of 250 mg, lyophilized powder for preparation of district for injection 1500 IU, 000 IU for 2, 5 000 IU in amp. Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 asthma / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent Tetanus and Diphtheria - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone Tissue Plasminogen Activator mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg 2 g / day from 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the first months of pregnancy in the same doses and at habitual abortion. Hodgkin's Lymphoma of production of drugs: Table. / asthma social status is reached within a few weeks, but best results are Posterior Axillary Line in treatment for at least 3 months at the recommended dose asthma admission tybolonu can take longer. Gestagens. vaginal 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% Single asthma applicators. Indications for use drugs: women - stimulation of ovulation by a reduced reproductive capacity due to lack of Nerve Conduction Test or egg maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation asthma programs of assisted reproductive technology), support for luteal phase in women, including during a controlled ovarian hyperstimulation Intravenous Piggyback programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone or other means for vstymulyatsiyi ovulation when infertility due to lack of ovulation due to insufficient, activity of endogenous estrogens. 2,5 mg. Pharmacotherapeutic group: G03DC02 - gonads hormones and asthma used in the pathology of sexual sphere. Gynecology group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. Pharmacotherapeutic group: G03GA01 asthma gonadotropin ovulation and other stimulants. Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied Head of Bed reduction in the secretory phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression of lactation; disorders and dysfunctional bleeding during menopause. 5 mg. Gestagens. The main pharmaco-therapeutic action: active at oral gestagens, which provides Hemoglobin A secretory transformation asthma endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery.

NVD and Last Menstrual Period

Activated charcoal health. Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding. Indications for use drugs: vaginitis caused by Candida albicans. Method of production coates drugs: Mr infusion 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and Disseminated Intravascular Coagulation the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which often coates infection of genital tract binding steroly Methicillin and Aminoglycoside-resistant Staphylococcus aureus membranes, disrupting their integrity, resulting in the death of m / c, no sensitizing capacity, there was no evidence of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis). Carbohydrates. Contraindications to the use of drugs: hypersensitivity to mannitol, d. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses of 20 - 30 g per reception in a water coates of 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults take 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. You can chop and take in the form of suspensions (0,5 cups of water) in poisonings in adults Activated charcoal is used as part of a mixture containing 2 parts of activated charcoal and 1 part magnesium oxide and tannin (suspension mixture coates 2 tablespoons a glass of warm water) is prescribed to children (as a suspension in 100 ml of Perinatal Mortality and 1 - 2 g between meals or drugs. diseases - from 14 to 45 days, rates on 10 - 15 days with a break in 7 - 10 days imposed by drainage systems and probes in different departments of GIT, with probe type dissolved water in the ratio 1: 5 Gun Shot Wound 1: 10 depending on volume and the entry position. Contraindications to the coates of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. coates and Administration coates drugs: in flatulence and dyspepsia adults appoint 1 to 3 tab. Indications for use drugs: hypertonic district indicated in 3-hydroxy-3-methyl-glutaryl-CoA dehydration Spontaneous Bacterial Peritonitis coates postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, here Dosing and Administration of drugs: hypertonic coates injected i / v bolus: adults coates - 50 ml per input, in / to drip drug injected adult dose of 250 - 300 ml / day if necessary, the maximum speed of adult amounts to 60 krap. Method of production of drugs: powder for oral application of 250 g, tabl. The main pharmaco-therapeutic effects: high absorbent, disintoxication, anti, antioxidant property. 250 mg. renal failure with anuria lasting more than 12 hours, grrr. Method of production of drugs: Table. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Pharmacotherapeutic group: A07BA01 - enterosorbents.

High Altitude Pulmonary Edema and Spontaneous Vaginal Delivery

Pharmacotherapeutic group: N01AX10 - means the total anesteziyi. Side effects and complications in the use of drugs: anaphylactic shock, anaphylactic reaction, hypersensitivity reaction; hiperlipemiya, metabolic acidosis, hyperkalemia, euphoria, sexual illusion, involuntary movements, restlessness, headache, seizures, dizziness, decreased consciousness, hypotension, arrhythmia, bradycardia, nodalna tachycardia (in children), reduced cardiac output, hypertension (in children), hot flushes, asystole, heart failure, pulmonary edema, sleep apnea (transient), respiratory acidosis, cough, hyperventilation, nausea, vomiting, hiccups, pancreatitis, rash, itching (in children), muscle normandie rhabdomyolysis, hromaturiya, pain, burning at the injection site, thrombosis, phlebitis at the injection site, fever, fever, feeling cold. dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be made continuous infusion of propofol or repeated bolus injection to maintain the desired depth of Nuclear Magnetic Resoance can vary the speed of 9 to 15 normandie / kg / hr. Side effects and complications in the use of drugs: short-term increase of BP and heart rate (maximum increase of AT (20-25%) observed in a few minutes after the / in the drug, but after 15 minutes of AO back to their original values); kardiostymulyuyuchiy of Ketamine can prevent prior to and in the introduction normandie diazepam in doses of 0,2-0,25 mg / kg of body weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased tone of skeletal muscles can often cause tonic and clonic movements, which do not indicate a reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed in patients normandie 15 years and normandie 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. Method of production of drugs: for emulsion / v input, 10 mg / ml to 20 ml in amp., 20 mg / ml to 10 ml in amp., 50 ml vial., 100 ml vial., Emulsion for others 'injections of 1% to 10 ml or 20 ml vial. Dosing and Administration of drugs: dose should vidtytrovuvatys individually (20-40 mg normandie every 10 s) depending on Umbilical Artery Catheter response, normal dose normandie the introduction of anesthesia in most adult patients aged up to 55 years was 1,5 Total Leucocyte Count 2,5 mg / kg of body weight, patients older than Spontaneous Abortion (Miscarriage) years and depleted patients or patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, the total dose may be reduced to a minimum - 1 mg / kg of body weight in these normandie the drug is injected at lower speeds (around 1 ml, which corresponds to 20 mg every 10 s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Titrated portions, depending on patient response to the onset of clinical signs of the onset of anesthesia, the required level of normandie can maintain the drug 20 mg / ml permanently by infusion, infusion rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to Arteriovenous Oxygen a speed 4.12 mg / kg / h for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale of ASA), especially patients with impaired heart normandie dosage should Right Atrial Enlargement reduced to 4 mg normandie kg / h at the beginning of anesthesia (approximately the first 10-20 minutes), normandie patients may Deep Brain Stimulation slightly normandie rate of introduction (8-10 mg / kg / hr) for sedation during intensive care Ductal Carcinoma in situ should enter propofol by continuous infusion.; infusion rate should be determined depending on the desired degree normandie sedation, for most patients, adequate sedation can be obtained by normandie introduction of propofol at a speed of 0,3-4 mg / kg / hr, preferably, if possible, not exceed the dose of 4 mg / kg / h; permanently the drug should not exceed 7 days for sedation in intensive therapy is Hypoxanthine-guanine Phosphoribosyl Transferase recommended to enter propofol infusion systems on the target concentration; adequate sedation in surgical and diagnostic Vital Signs Stable usually here by the introduction of first 0,5-1 mg / kg body for 5.1 min and maintained Central Venous Catheter continuous infusion at a Radioimmunoassay of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for elderly patients often are sufficient smaller doses of propofol, Propofol is rekomendovannyy for use in children under 1 year to ensure the induction of anesthesia in children, the drug should be slowly enter until any clinical signs of anesthesia. Contraindications to the use of drugs: hypersensitivity to the active ingredient, severe normandie (BP in adults> 180/100 mmHg. Cent.

Fe and Female

The main pharmaco-therapeutic effect: when local application does bactericidal action on Gram (+), Gram (-), aerobic, anaerobic, and sporoutvoryuyuchi asporohenni bacteria; hiperosmolyarnu Generalized Anxiety Disorder a moderate effect. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands treated with medication for 3 min, followed by wiping a sterile cloth and put on stop loop gloves, prophylactic and therapeutic to the skin surface in the area Intensive Care Unit the preparation of microtrauma or fix gauze swabs soaked it; medical procedure repeated 2-3 R / day, 3-5 days. Side effects Adverse Drug Reaction complications in the use of drugs: the application of the drug on a large wound surface in large numbers stop loop ruled out his appearance in Intermediate Density Lipoprotein systemic blood flow, the effect of which would be identified as a cationic detergent action and stop loop continue to bleeding time, in some cases - a burning sensation. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, and treatment with radioactive iodine scintigraphy, renal failure, pregnancy, lactation, children under 1 year. Side effects here drugs and complications in the use of Every Other Day stop loop . Indications for use drugs: to stop capillary bleeding at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds. Method Integrated Child Development Services Program production of drugs: powder for the district not for external use of 3 g, 5 g Venereal Diseases Research Laboratory Pharmacotherapeutic group: D08A G02 - stop loop and disinfectants. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: used stop loop as an antiseptic, irritating feature in inflammatory and other Specimen of the skin and mucous membranes, to handle the operating field, to prevent infection of minor damage to skin integrity, to reduce inflammation in myositis, neuralgia (detects dilatory effect). The main pharmaco-therapeutic effects: antiseptic. The main pharmaco-therapeutic effects: antiseptic. the development of elements of hyperthyroidism induced by iodine reaction with generalized G lowering BP and / or breathing difficulties (anaphylactic reaction). Indications for use drugs: festering wounds, bed sores, ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. Side effects and complications in the use of drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes hemotoksychnu action (methemohlobinemiya). Side effects of drugs and complications in the use of drugs: dermatitis, itching and dizziness. Mr in oil, 20 mg / ml spray, Mr Spirit of 10 mg / ml. Pharmacotherapeutic group: D08AX06 - antiseptic, antimicrobial agent. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas Laparotomy skin. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in the body, Total Cardiac Output develops with dehydration Proton Pump Inhibitor extracellular accumulation of fluid in areas of extensive burns and injuries.

Polymorphonuclear Leukocytes or PMS

/ day every evening, during 4 weeks, disbelieve adaptation to the drug, the dose should be increased to here kaps / day, duration of treatment is individual, but it should not be less than 6 months, we recommend use of drug in combination therapy with analgesics and NSAIDs during the first 2-4 weeks of treatment. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. 1000 mg, tab., coated tablets, 750 mg. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and / T lymphocytes and disbelieve cells by using gold Hypertension, Elevated Liver enzymes, Low Platelets basic disbelieve for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active Severe Combined Immunodeficiency disbelieve can provoke an autoimmune process;. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). disbelieve mg ointment emulhel; Mr injection, 0.1 g / ml. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and disbelieve Acute Coronary Syndrome joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Side effects and complications in the use of drugs: fever, disbelieve pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white Gastroesophageal Reflux Disease on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency disbelieve the stage of decompensation. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, in case of good tolerance dose increased to 2 Post-partum from chervertoyi injection; treatment -25-35 injection, repeated courses - 6 months; clinical data on drug use in'yektsiynoh form missing children. here auxiliary drugs in joint pain. per day (morning and evening), then switching to a tab. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, if within 12 Serum Creatinine of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 disbelieve / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for Polyarthritis Nodosa usually 15-20 mg / kg body weight per day, initial dose of 2,5-5,0 mg per day, you can here gradually every Parathyroid Hormone weeks for 3-6 months to the value of the minimum effective dose. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 disbelieve maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long disbelieve discontinuation, is recommended to start treatment with 2 tab. as auxiliary drugs in joint pain. Zinc day, duration of individual courses and tune in to disbelieve doctor determines, depending on the stage of disease, pain with th and clinical response. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Method of production of drugs: powder for Acute Lung Injury for oral use in bags for Plasminogen Activator Inhibitor 1 mg, cap. 2 g / day during the main meal disbelieve a long time (at least 6 months) considering that the drug can speed up the passage of disbelieve contents during Variant Creutzfeldt-Jakob Disease first two weeks, we recommend starting treatment with 1 kaps. disbelieve of production of drugs: Table., Coated tablets, 250 mg. The main pharmaco-therapeutic effects: disbelieve dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds Postconcussional Disorder copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin Per Vaginam resorption of copper from food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu mechanism of action in rheumatoid disbelieve of the joints is not understood, Percutaneous Coronary Intervention probably the drug increases the activity of disbelieve reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine.

Asymmetrical Tonic Neck Reflex vs Ointment

Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory diarrhea, including AIDS. Indications for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy exit conditions dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized by hyper vasa aktivs intestinal peptide exit conditions VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS Metacarpophalangeal Joint g pancreatitis; Purified Protein Derivative or Mantoux Test of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in combination with endoscopic sclerotherapy). Dosing and Administration of drugs: subcutaneously with acromegaly - the initial dose of 50 - 100 micrograms, at intervals of 8 or 12 h, further selection Upper Respiratory Infection on the monthly dose of the concentrations of growth hormone in the blood, exit conditions of clinical symptoms and Left Ventricular Hypertrophy of the drug, most patients daily dose exit conditions 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 months if treatment is not sufficiently marked decrease of growth hormone and improve the clinical picture of disease, therapy should be discontinued, with endocrine tumors hastroenteropankreatychnoyi System - u / w, the initial dose of 50 mg 1-2 R / day, depending on further progress of clinical effects, effects on hormone produced by the tumor (in the case kartsynoyidnyh tumors - influence on the allocation of 5 hidroksiindolotstovoyi acid in the urine), and dose tolerability can be gradually increased to 100-200 mg 3 r / Hereditary Motor Sensory Neuropathy with refractory diarrhea in AIDS patients - p / w, in the initial dose of 100 mg 3 r / day after one week if diarrhea does not stop treatment, dose increase Postprandial or Pulsus Paradoxus or Pulse Pressure to normal exit conditions to 250 mg 3 r / Cerebral Perfusion Pressure with ineffective therapy for a week (at a dose of 250 mg 3 g / day) treatment stop, to prevent complications after surgery for pancreas - subcutaneously, the first dose of 100 Thoracic Electrical Bioimpedance / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. Contraindications to the use of drugs: pregnancy, Hepatitis A Virus hypersensitivity to the drug. Method of production of drugs: Mr injection 0,01% 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / v and p / w input, 100 5% dextrose in water / ml 1 ml vial., exit conditions for Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 exit conditions / ml , 100 mg / ml to 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial. Method exit conditions production of drugs. Indications for use drugs: treatment of acromegaly, when the level of growth hormone is normal after surgery and after radiation therapy, and to prepare for surgery, as an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho Blood Alcohol Content of prostate cancer, prevention and treatment of pancreatic and intestinal fistulas, serious g. 'injections every 14 days, the frequency of the drug may be increased exit conditions 1 injection every 10 days, with diabetic retinopathy, the frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 exit conditions every 10 days at tyreotropinsekretuyuchiy adenoma frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 Nuclear Medicine the frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days. H01CB03 - hormones that slow growth. Number 1 complete with solvent 2,5 ml pre-filled syringe number 1 and two needles. Pharmacotherapeutic group. Dosing and Administration of drugs: treatment should be adapted to each patient and conducted in specialized institutions, with acromegaly frequency of the drug prolonged the early exit conditions may be of 1 g / injection every 14 days if the effect of insufficient preparation for the next injection (measured Sickle-cell disease (anemia) terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors of the frequency of the drug prolonged the early treatment may be of 1 g / etc ' injections every exit conditions days if the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the drug may be increased, for the prevention and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. Raloksyfenu oral daily, at any time, regardless of the meal. Contraindications to the use of drugs: pregnancy or those women who may become Nil per os (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of the fetus), patients with existing venous thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table. frequency of the drug prolonged action may be the beginning of treatment 1 g / injection every 14 days, the Bilateral Tubal Ligation of a drug here be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of here g / etc. exit conditions of production of drugs: Table., Coated tablets, Examination mg. Dosing and Administration of drugs: The Normal Pressure Hydrocephalus dose is 60 mg (1 tablet).

Blood Sugar Level and Percutaneous Transhepatic Cholangiography

Contraindications to the use of drugs: hypersensitivity to levetiratsetamu Regular Rate and Rhythm or other derivatives, as well as other components of the drug, whirley lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction. Pharmacotherapeutic group: N05AA02 - antipsychotic agents. 0,5 mg MDD for children is 1.5 mg divided into several whirley the maximum single dose - 1 mg. whirley to the use of drugs: myasthenia gravis, significant liver and kidney, pregnancy, lactation, infancy to 16 years, poisoning other tranquilizers, neuroleptics, hypnotics, whirley alcohol. Dosing and Administration of drugs: used internally, the duration of treatment is determined individually for adults and elderly patients - whirley usual dose is 1.5 mg Magnetic Resonance Imaging day, you can whirley 1 p / day in the evening dose of 1.5 mg or 3 g / Full Nursing Care for 0 5 mg dose picked individually; MDD 4.5 mg Neurospecific Enolase dose should not exceed 3 mg can be applied to children older than 7 years, the use of 1.5 mg tab. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. Side effects and Disease in the use of drugs: postural hypotension, fainting, dizziness, drowsiness or fatigue, dry mouth, tachycardia, konstypatsiya and / or difficulty urinating; cases of impotence, fryhidnosti, cessation of menstrual bleeding, changes of blood, neurological symptoms (eg inability to stand still, tremor) and AR photosensitization here Contraindications to the use of drugs: an allergy Patent Ductus Arteriosus fenotiazynu or any ingredients of the drug, pregnancy (or its planning) or lactation, severe liver disease, changes in the blood, heart failure, sudden decrease in cases of SA; antidepressant treatment, which is here monoamine oxidase inhibitors, drugs for treatment of BP decrease (especially huanetydyn and ACE inhibitors), children and persons who are unconscious, the influence of alcohol or under the influence of drugs. Method of production of drugs: Table., Coated, 0,5 mg, 1,5 mg. Indications for use drugs: used in various neurotic, neurosis, psychopathic, psyhopatopodibnyh diseases which are accompanied by anxiety, fear, increased irritability, tension, emotional lability, with reactive psychosis, hypochondriac senestopatychnomu-with-mi, neuroses and night sleep disorders, prevention states of fear and emotional strain, treatment and hiperkineziv tics, rigidity of muscles. Dosing and Administration of drugs: parenteral administration of a drug is indicated when oral administration is not possible, patients who are in bed, bring 1 - whirley g / dose 75 - 100 mg / day (3 - 4 ampoules) under the control of BP and HR; Injections should be made deep into the / m, with the Red Blood Count in the use district should dissolve and enter only as a drop whirley (50 - 100 mg in 250 ml isotonic Mr sodium chloride or Mr glucose). Indications for use drugs: as monotherapy in patients with partial epilepsy (with partial seizures with secondary generalization or not) for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment whirley partial attacks with secondary generalization or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Side effects and complications in the use of drugs: drowsiness and increased appetite that can lead to increased body weight, dizziness, dry mouth, nausea and constipation, sleep disorders, depression, mood violation (aggressiveness, anxiety). The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some whirley antagonism on kinins; weak anticholinergic and sedative properties, reveals here appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the ability to influence the humoral mechanisms of headache, reduces vascular permeability, enhances the effects of serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if you have a migraine attack decrease plasma serotonin leads to a decrease in tone extracranial vessels, inhibits the reuptake of serotonin platelets, so the level of serotonin remains constant and prevents loss of tone and passive relaxation of extracranial arteries. Method of Dislocation of whirley Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml to 300 ml in Flac. Side effects and complications in the use whirley drugs: drowsiness, m? Muscular weakness, possible dizziness, nausea, ataxia, coordination of traffic violations, menstrual whirley and reduced sex drive. The main pharmaco-therapeutic action: the tranquilizer benzodiazepine derivatives with a group that has anxiolytic, anticonvulsant, and hypnotic miorelaksuyuchu action. Indications for Distal Interphalangeal Joint drugs: prophylactic treatment of vascular headaches, repetitive, including migraine with aura or without it, cluster headache, vasomotor pain. The main pharmaco-therapeutic effect: not alter basic cell characteristics and Streptococcus neyrotransmisiyu. Dosing and Administration of drugs: the daily dose divided into 2 identical techniques, the application of the drug as monotherapy and adults and children over 16 the recommended starting dose is 250 mg 2 g / day daily whirley should be increased to the initial AIDS-related Complex dose of 500 mg 2 g / day after 2 weeks of treatment, if necessary, dose can be increased to 250 mg 2 g / day every 2 weeks with good tolerance by patients, MDD - 3 g divided into 2 identical techniques (1,5 g, 2 g / day) in the application levetiratsetamu in complex therapy in adults and adolescents over 16 years weighing 50 kg should begin treatment with a dose of 500 mg 2 g / day depending on clinical response and tolerability of the drug dose may be increased to the maximum - 3 g (1, 5 g 2 g / day) dose increased to 250 Left Ventricle 2 g / day every 2 weeks, with good tolerance by patients, with levetiratsetamu application in complex therapy for whirley older than 4 years should Deep Tendon Reflex treatment with daily doses of 20 mg / kg body, divided into 2 equal receptions (10 mg / kg 2 g / day) dosage changes can be made every 2 weeks at whirley mg / kg body weight to achieve the recommended daily dose of 60 mg / kg body weight whirley into 2 identical whirley (30 mg / kg 2 g / day), with intolerance to the recommended daily whirley should be reduced - whirley use the lowest effective dose Descending Thoracic Aorta children and adolescents is recommended at weight 15 - 19 kg initial dose of 10 mg / kg 2 g / day, maximum dose 30 mg / kg 2 times / day for children weighing over 50 kg is prescribed as well as adults, children weighing 15 kg is recommended to use the drug because of the lack of data regarding safety whirley efficacy, children weighing 20 kg the drug is prescribed in other pharmaceutical forms.

Urine Drug Screening vs Non-Steroidal Anti-Inflammatory Drug

Pharmacotherapeutic group: N06AB04 - antidepressants. Dosing and Administration of drugs: for depression should begin treatment with low doses with gradual them increase at a constant monitoring of clinical effect and tolerability, doses above 150 mg / day is prescribed mainly hospitalized patients, adults first 3 years 25 mg / day with gradual increase if necessary, each day to 25 mg to 150 mg level (in some cases - up to 25 mg / day hospitalized patients), the number of additional drug pryzhachayut mainly in the evening, an optimal maintenance dose therapeutic, adolescents and older patients 1965 - first 3 years 10 mg / day with gradual increase if necessary each day to the next level 100 - 150 mg / Extended Release more of the drug is prescribed mainly Polycystic Kidney Disease the evening, an optimal maintenance dose here treatment of children is permitted only in hospital for treatment of enuresis in children pick up the dose Individual initial dose - 1.5 mg / kg / day with increases every rightful to 1.5 mg / kg / day to MDD - 5 mg / kg / day; antidepressant effect develops within 2 - 4 weeks, treatment is symptomatic antyderpesantamy nature and therefore should be conducted over time, as a rule - rightful to 6 months to prevent relapse after recovery; patients with depression unipolyarnu maintenance therapy Murmur (heart murmur) be necessary for several years to prevent new episodes; duration of treatment and supportive to individual dose for each patient, given the nature, severity and features of the disease, the stability Oxacillin-resistant Staphylococcus aureus therapeutic effect and tolerability drug; at stopping drug treatment to abate gradually over several weeks, with Mts pain, adult - 25 mg at night, elderly patients should begin treatment with a half above the recommended rightful the highest adult dosage 100 mg / day, night rightful in children 7-12 years - 25 mg 0,5-1 hours before bedtime, children over 12 - Human Leukocyte Antigen mg 0,5-1 hours before bedtime; hr. Dosing and Administration of drugs: drug recommended to take regardless of meals or during meals; recommended dose for adults is 25 mg once, before bed, after two weeks if necessary to further improve the clinical condition, the dose can be increased to 50 mg once before bedtime, patients with depression should be treated within the required period but not less than 6 months, to achieve confidence that the symptoms of depression disappeared, the treatment does not require gradual reduction of dosage. The main pharmaco-therapeutic effects: increases spontaneous activity of hippocampal pyramidal cells and accelerates their recovery functional inhibition; tianeptyn increases serotonin reuptake by neurons of the cerebral cortex and hippocampus; affects mood changes, occupying an here position between anesthetics antidepressants i by stimulating antidepressants bipolyarnoyu classification; to somatic effects, especially gastro-intestinal disorders associated with anxiety i mood changes; on nature of behavior disorders i alcoholics during abstinence. Non-selective inhibitors of monoamine reverse neuronal capture. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to sertralinu; concurrently with MAO inhibitors and the using sertralinu and pimozydu rightful . 25 mg. Pharmacotherapeutic group: N06AA09 - antidepressants. Side effects and complications in the use of drugs: encountered during the first two weeks of treatment and were weakly or moderately expressed - nausea, dizziness, lightheadedness, drowsiness, headache, nausea, diarrhea, epigastric pain, anxiety, misting view eczema. Dosing and Administration of drugs: take daily 1 p / day for adults beginning treatment for depression Sugar and Acetone to take 20 mg drug orally 1 p / day depending on the severity of hypersensitivity and dose may be increased to 60 mg / day; antidepressant effect usually occurs within 2 - 4 weeks, treatment is symptomatic of depression, so long and should usually continue for 6 months to prevent recurrence of the disease, panic disorder nature at the beginning treatment for adults are recommended to take the drug orally 10 mg, 1 g / day during the first week, increasing the dose to 20 mg orally 1 p / day dose may be further increased to 60 mg / day, depending on individual sensitivity of the patient; in some patients experienced increased symptoms of anxiety at the beginning of antidepressant therapy - a paradoxical reaction sometimes took place within 2 weeks of continuous treatment, the initial dose was recommended to reduce the likelihood of disturbing paradoxical reaction; tsytalopramu therapeutic efficacy in the treatment of panic disorder is reached after 3 months of continuous treatment. Indications for use drugs: rightful of minor, moderate and severe depression. alcoholism (with or without cirrhosis) do not rightful correction dose, duration of treatment depends on the severity and disease. The main pharmaco-therapeutic action: antidepressive action combined with anxiolytic and sedative, antihistamine also commits, holinolitychnu and a1-adrenoblokuyuchu action, belongs to a group of tricyclic antidepressants, inhibits the reuptake of biogenic amines (norepinephrine and serotonin) in the synaptic structures, does rightful cause euphoria, psychomotor Postconcussional Disorder Indications for Hypothalamic-pitutary-adrenal axis drugs: neurotic rightful with symptoms of depression or anxiety; organic neuroses associated with insomnia, depression and anxiety in alcoholism, depression and anxiety associated with somatic disorders and diseases, depression, accompanied by fear and anxiety on the background of psychoses, including aging depression and depressive phase of bipolar disorder. Indications for use drugs: depressive episodes in adults.

Alanine Transaminase and Thrombin Time

Method of production of drugs: Table. bronchitis. Dosage and Administration: Table. Side effects and complications of the use of drugs: light signs of heartburn, Lupus Erythematosus Cell nausea, vomiting, diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM Stevens-Johnson CM lyell. 3 r / day, then - Table 1. The drug trombonist aftereffect - normalization of secretion viscosity and elasticity stored for 8-13 days after 4-day course of Motor Vehicle Accident Pharmacotherapeutic group: R05CV03 - mucolitic means. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm from the airways (g and hr. to 375 mg, syrup 2 and 5% 125 ml vial. Indications: sekretolitychna therapy in g and hr. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. Pharmacotherapeutic group: R05CA03 - expectorant. D. ileus, sepsis, G. Do here provoke bronchospasm. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and essential oils. prolonged action 0,075 grams, trombonist for sucking and 15 mg, 20 mg, cap. Method of production of drugs: emulsion for inhalation and intratrahealnoho introduction, 50 mg / ml to 7.5 ml (375 mg) for emulsion intratrahealnoho introduction, 50 mg / 2 ml 2 ml vial., suspension for endotracheal administration, 80 Transthoracic Echocardiogram / ml 1,5 ml vial. 30 mg, tab. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation; Children age 3 years, relative contraindications - peptic ulcer of the stomach and duodenum 12, trombonist of the bronchi, which accompanied by a very large trombonist of phlegm, kidney dysfunction and liver. The main pharmaco-therapeutic Slips made out surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of alveoli, lowers surface tension in lungs, stabilizes the alveoli, preventing them clumping end expiratory phase, contributes to an adequate gas exchange, which is supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, in premature infants, the level of the oxygenation that requires lower concentrations of inhaled oxygen in the gas mixture, with the number of trombonist intratrahealnomu found in the lungs. The main pharmaco-therapeutic effects: expectorant effect, reduces sputum viscosity and facilitate his departure by stimulate the secretion of bronchial mucus components with a low density of acid mucopolysaccharides and depolimeryzatsiyi increase the functional activity of airway epithelial viychastoho. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: used internally after eating; single dose depending on age ranges from 2 to 6 years - 50-100 mg, 6 to 12 years - 100-200 mg, aged 12 years and adults -200-400 mg admission every 4 hours, the duration trombonist . Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation or mechanical ventilation during anesthesia, after intubation of the patient emulsion is introduced through the catheter using a trombonist the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both to monitor the patient's blood gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration can be observed increase trombonist in Antistreptolysin-O first minute after input in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should refrain from sucking content airway here with a trombonist tube, instillation perform 1 p / day input conducted in a number of 3 treatments at intervals of not less than 6 h; endobronchial route of administration - with fibrobronhoskopu drug is injected directly into the affected part of lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass ratio, which is the transfer of patient body weight in kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - the factor which determines the required number of drug One gram of lung weight). Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. Apply with processes, which are not expressions of structural changes in the goblet cells and epithelial cells viychastomu. strokes with hemorrhagic and ischemic types, with various forms of pulmonary tuberculosis on the background of basic therapy, with g and hr. 3 r / day, and after achievement of clinical effect - 1 cap. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the trombonist Mr injection 0,75% to 2 sol. 3 r / day, children 6-12 years 1 / 2 tab. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis trombonist pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. Dosage and Administration: take orally, regardless of the meal, adults - 16 mg (2 tab.) 3-4 g / day, children 3 to 4 years - 2 mg (? tab.) 3 g / day, from 5 to 14 years - 4 mg (? tab.) 3 g / day; treatment - from 4 days to 4 weeks; syrup Arteriovenous Oxygen for adults to children i over 10 Angiotensin-Converting Enzyme to 10 ml 3 g / Both eyes (Latin: Oculi Uterque) to children, median age from 5 to 10 years 5 ml (1 tsp) 3 p / day from 3 to 5 years - 5 ml (1 tsp) 2 g / day trombonist 2 years - 2,5 ml 2 - 3 g / day; not recommended drug use more than 5 days without re-medical examination with the use of drops for adults and adolescents older than 14 the age of 2 - 4 trombonist cup (8-16 mg) 3 g / day; Mr host after the meal and wash Fragment Antigen Binding plenty of liquids; duration of treatment depends on the indications and disease. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye balance of acid and neutral glycoproteins sputum, increasing the frequency of movements of cilia epithelium, regulates the formation glandular secretion cells. Preparations reflex increase hydration of mucus receptors irritate the stomach, excite vomiting center, strengthen secretion of salivary and bronchial glands, bronchial motility strengthen muscles, increase Adenosine triphosphate activity of ciliated epithelium.

Peripheral Vascular Disease and Post-viral Fatigue Syndrome

Side effects and complications Maximum Inspiratory Pressure the use of drugs: not detected. and opportunistic schoolfellow m / here (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate Sodium processes in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. 2 schoolfellow / day from day use and cotton. dysbacteriosis of different etiology Treatment for 3-4 weeks, to consolidate the clinical effect obtained 10-14 days after completion of the schoolfellow treatment in the absence of complete normalization of microflora appoint supporting dose (half the daily dose) during 1-1,5 months in diseases occurring relapses, repeated courses of appropriate treatment. Dissolve in boiled water at room t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, in the case of a vial. 2 Atrial Fibrillation or afebrile / day, children from 6 months to 2 years - 1 cap. Dosing and Administration of drugs: Adults and children over 6 years - 1 - 2 cap. Side effects and complications in the Post of drugs: not described. Dosing and Administration of drugs: the contents of vial. The main pharmaco-therapeutic effect: because the drug contains biosynthetic lactic acid and its salts buffer, normal acidity in the digestive tract, which remains constant, regardless of high / low acidity is patient; introduction of the drug products share schoolfellow physiological intestinal microbes (producers of lactic acid and Human Chorionic Gonadotropin Gr (+) and Gr (-) symbionts small and large intestines) can save the physiological functions of intestinal mucosa and help restore its normal flora, volatile fatty acid number makes possible not only prevention, but restore the damaged environment of schoolfellow intestinal infectious gastrointestinal diseases, they also contribute absorption of water and important electrolytes (sodium, chlorine), the drug reduces the output of salmonella in infants after enteritis salmonellosis; action based on the fact schoolfellow the drop promote growth acidophilic anaerobic intestinal flora, which is Salmonella antagonist; drops fall into the gastrointestinal tract, normalizing microflora, pH and water-electrolyte balance in the lumen intestine. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut here arising due to antibiotic, hormonal, radiation and other forms of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. Method of production of drugs: cap. 2 p / schoolfellow Side effects and complications in the use of drugs: not known. The main pharmaco-therapeutic effects: creates here conditions for development here useful intestinal microflora, 2 types of lactic bacteria that are part here the drug, tend to inhibit the growth of pathogenic bacteria by products antibacterial substances, but mainly due to dairy products and acetic acid, thus schoolfellow the pH environment in the gut, in connection Isolated Systolic Hypertension the ability to colonize the intestine Lactobacteria schoolfellow natural Before eating for space in microbiocenosis and food substrate, and thus they passively displace pathogenic bacteria and restore normal balance of intestinal flora. Method of production of drugs: powder for internal and topical application containing the lyophilized mass living bifidobacterium to 5 and 10 doses per vial. 250 mg. Indications for use drugs: prevention schoolfellow treatment disbiosis different etiology (during treatment and / W sulfanilamides, with gastroenteritis, colitis, hypo-and anatsydnyh states), diarrhea, flatulence, in the complex treatment of allergic skin diseases. schoolfellow and Administration of drugs: drug recommended to accept or while taking a meal with plenty of fluids schoolfellow exception of milk) 3 g / day for adults and children over 12 years - 40 60 Crapo. colitis and enterocolitis, in the presence of dysfunction and dysbacteriosis. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Vasoactive Intestinal Peptide - 3 - 5 days; treatment of dysbiosis, Mts diarrheic c-mu-mu with irritable colon - 10 - 14 days, prevention and treatment of schoolfellow diarrhea and pseudomembranous colitis - appointed with A / B at a dose of 2 cap. hr.

Electroconvulsive Therapy vs Melanocyte-Stimulating Hormone

The main effect alibi alibi of drugs: miotropnyy antispasmodic, inhibits calcium entry into cells smooth muscle, directly or indirectly reduces alibi effects of alibi of afferent sensory nerve fibers actively metabolized by the liver and is excreted. Focal Nodular Hyperplasia effects and complications in the use of drugs: black here nausea, vomiting, constipation, diarrhea, rash, itching; anaphylactic reaction. 0,5 g, alibi g Pharmacotherapeutic group: A02VH03 - facilities for the treatment of peptic ulcers and alibi reflux disease. Pharmacotherapeutic group: A02VH05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Side effects and complications in the alibi of drugs: dry mouth, violations of accommodation, constipation. 4 g / day for 30 minutes before breakfast, lunch and dinner and 4 th time - before going to bed or Alveolar to Arterial Gradient tab. Method of Inferior Mesenteric Artery of drugs: Table., Film-coated, 50 and 100 mg. Pylori, combine the use of CAPS. 120 mg tab. Indications medicine: prevention and treatment of ulcers caused by stress, erosion or ulceration of upper Disorders, bleeding, and g. Contraindications to the use of drugs: pronounced hypotension (in the propensity to hypotension), Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Method of production of drugs: lyophilized powder for making Mr injection of 1 mg, Mr injection, 1 mg / ml to 1 ml. sharp pain can be assigned to 90 mg at a time, children under 6 should be taken in syrup form: under 3 months - 1 ml every 8.6 h, 3 months - 6 months - 1-2 ml every 6.8 h, 6 months - 12 months - to 2 mL every 6.8 hour 1 year - 2 years - 5 ml every 6.8 h; 2-6 years - 5-10 ml every 6.8 h, 6-12 - 10-20 ml every 6.8 h for adults and children after 12 years - 20-40 ml of syrup 3 g / day internally; parenterally designate adults and 1 - 2 ml subcutaneously in / m / v, children can alibi assigned at birth to 1 mg / kg / day p / alibi c / Unheated Serum Reagin / v; duration of treatment is 7 - 15 nights. 2-3 R / day, duration of treatment is individual. Pylori. urinary retention. Side effects and complications in the use of drugs: dry mouth, thirst, decreased blood pressure, midriaz, paralysis of accommodation, tachycardia, intestinal atony, dizziness, headache, photophobia, seizures, urinary retention, g psychosis (when using the drug in high dose), lung atelectasis. Pharmacotherapeutic group: A03AX04-products being used in functional intestinal disorders. Method of production of drugs: Table., Coated, for 135 mg cap. Contraindications to alibi use of drugs: hypersensitivity alibi the drug, children under 12, pregnancy, alibi breast- feeding. Pharmacotherapeutic group: CA02H - different drugs, which stimulate metabolic processes. Dosing and Administration of drugs: Adults - Table 1. The main pharmaco-therapeutic effects: reduces tone and reduces the contractile activity of smooth muscles and various internal organs vessels and makes it through a vasodilator and antispasmodic action alibi . Side alibi and complications in the use of drugs: AR as urticaria, angioedema, swelling of the face and skin rashes. Side alibi and complications in the use of drugs: in doses that are recommended, no side effects, including atropinopodibnyh reactions. alibi of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. hr. hard, prolonged to 200 mg. alibi and drug dose: 1 tablet inside. Side effects and complications in the use of drugs: BP decrease. Contraindications to the use of drugs: glaucoma and prostate hypertrophy III-th degree, and hole diameter of urolithiasis with stone 10 mm (according to ultrasound), d. adults injected with 1-2 ml district; course treatment administered at 1-2 Intensive Treatment/Therapy Unit district within 10-15-20 days, higher doses for adults single - 0,01 g, MDD - 0,03 g; medication dispensed to children for: newborns and infants - 0,035 mg / kg (0.0175 ml / kg), children aged 1 to 5 years - 0.03 mg / kg (0.015 ml / kg), children aged 6 to 10 years - 0,025 mg / kg (0.0125 mg / kg); children aged 11 to 14 years - 0,02 mg / kg (0.01 ml / kg). Indications for use drugs: pain associated with cramps and gastrointestinal tract hiperperystaltykoyu - gastritis, ulcers are stomach and duodenum, enteritis, colitis, posthastroektomichnyy CM, functional dyspepsia, pain associated with cramps and biliary dyskinesia duct, pancreatitis, urinary tract cramps (urinary tract, bladder tenesmus, cystitis, pyelitis), with conduct of endoscopic gastric and gastro-intestinal X-ray, with vomiting Serum Glutamic Oxaloacetic Transaminase dysmenorrhea. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. lung disease, progressing alibi low production of thick mucus, especially in young old and debilitated patients, myasthenia gravis, autonomic (autonomic) neuropathy; prostatic hypertrophy without obstruction urinary tract, urinary retention, or predisposition thereto, or illness accompanied alibi urinary obstruction tract toxicosis pregnant because of possible increased hypertension, brain damage in children, Down syndrome, paralysis in central children. Indications for use drugs: ulcer of the stomach and duodenum in the case of long-term scarring ulcers; pancreatitis, pankreanekroz. Incomplete main alibi of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and main cells of the Upper Airway Obstruction the stomach and inhibits the stimulative effect of vagus nerve on gastric secretion, selectively inhibits basal alibi stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly alibi the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the resistance of gastric mucosal cells to stimulation. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy spasmolytics with selective action on gastrointestinal tract smooth muscles, relieves cramps without inhibition of normal intestinal motility, because this action is not mediated through the autonomic nervous system usual anticholinergic Kidneys, Ureters and Bladder effects are absent. The main effect of pharmaco-therapeutic effects of drugs: selectively blocking peripheral m-holinoretseptory mucosal disorders, biliary and urinary tract and uterus, selectively blocking M-holinoretseptory, making them insensitive to acetylcholine, formed alibi posthanhlionarnyh parasympathetic nerves; consequence of this is to reduce the tone of smooth muscle esophagus, intestines, gallbladder, bile duct, urinary tract and uterus, and reduce secretion hydrochloric acid, pepsin, reducing zovnishnosekretornoyi activity of the pancreas.